Evaxion is building a unique pipeline of highly efficacious prophylactic vaccines and antibodies with a high unmet medical need against serious infectious diseases.
Evaxion is rapidly expanding the preclinical pipeline to any bacterial infectious disease, proving the ground-breaking potential of EDEN Technology.
We can generate and test new vaccine and antibody candidates in animals in a matter of weeks, dramatically accelerating the speed of vaccine and antibody development, as well as reducing the cost and risk associated with discovery and preclinical development vaccines and antibodies
S. aureus (subunit vaccine)
P. aeruginosa (subunit vaccine)
K. pneumoniae (subunit vaccine)
A. baumannii (subunit vaccine)
© Copyright 2015 Evaxion Biotech All rights reserved